We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




DNA Microcircuits May Replace Silicon Chips

By Biotechdaily staff writers
Posted on 11 Dec 2003
Researchers have used modified DNA molecules in combination with carbon nanotubes to create microscopic electrical circuits that may someday replace silicon chips as the basis for a new generation of super fast computers. More...


Investigators at the Technion-Israel Institute of Technology (Haifa, Israel; www.technion.ac.il) attached carbon nanotubes, known for their extraordinary electronic properties, onto specific sites on strands of DNA. During the process the DNA was coated with a bacterial protein that directed the binding of the one nanometer in diameter nanotubes to a specific site on the DNA. Subsequently, the DNA was coated with gold particles. The bacterial protein protected the area of the bound nanotube, so only the ends of the DNA molecule were coated. The study was published in the November 21, 2003, issue of Science.

"The DNA serves as a scaffold, a template that will determine where the carbon nanotubes will sit,” explained senior author Dr. Erez Braun, associate professor of physics at the Technion. "There are some points where nature smiles upon you, and this was one of those points. Carbon nanotubes are naturally rigid structures, and the protein coating makes the DNA strand rigid as well. The two rigid rods will align parallel to each other, thus making an ideal DNA-nanotube construct. In a nutshell, what this does is create a self-assembling carbon nanotube circuit.”





Related Links:
Technion-Israel Institute of Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Immunoassay Analyzer
Procise DX
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.